Engflag

Prednicarbate Ointment

Quick links to important sections

Prednicarbate Ointment

Prednicarbate Ointment_EN

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prednicarbate Ointment

Quick Facts

Property Description
Active ingredient Prednicarbate
Form Ointment (Topical Dermatologic)
Pharmacological class Topical Corticosteroid (Glucocorticoid)
General purpose Relief of inflammatory and pruritic skin manifestations
Origin Synthetic, Non-fluorinated Prednisolone Derivative

What Type of Medicine is Prednicarbate?

Prednicarbate Ointment is a prescription-only drug whose active ingredient is Prednicarbate, a medication classified in the pharmacological class of topical corticosteroids, also known as glucocorticoids. The active compound is synthetic, structurally derived from prednisolone, and is notably distinguished as a non-fluorinated corticosteroid. This specific design is clinically recognized for delivering potent anti-inflammatory effects while aiming to minimize specific risks associated with certain halogenated structures.

The medication is consistently rated in the medium-potency corticosteroid range. This classification establishes its role as an effective anti-inflammatory and antipruritic agent for localized skin issues.

Composition and Dosage Form

The physical presentation of this medication is typically a topical Ointment, intended exclusively for topical dermatologic use. Prednicarbate Ointment is a single-ingredient product where the active ingredient is dispersed in a specialized base. The high-level composition includes Prednicarbate within a petrolatum-based vehicle, which is a compositional feature characteristic of the ointment form. This specific base is often selected for treating dry, thickened lesions due to its highly occlusive and moisturizing nature, enhancing the drug's efficacy on chronic skin inflammation.

What is the General Purpose of Prednicarbate Ointment?

The general purpose of using Prednicarbate Ointment is to secure symptomatic relief from the physical manifestations of various inflammatory skin disorders. It provides relief by rapidly targeting and reducing the swelling, redness, and persistent itching that characterize these conditions. The drug's inherent anti-inflammatory and antipruritic properties allow it to effectively manage the signs and discomfort associated with conditions generally described as corticosteroid-responsive dermatoses. The overall therapeutic goal is the temporary control and suppression of these acute or chronic symptoms.

Regulatory References

  1. MedlinePlus

What side effects are possible with Prednicarbate Ointment?

Possible Side Effects and Safety Information

The safety profile for Prednicarbate Ointment, as documented in regulatory sources, is structured around local application-site reactions and the potential for systemic effects due to absorption of the corticosteroid.

Adverse reactions reported in controlled clinical studies primarily involve the Skin and Subcutaneous Tissue and were noted in approximately 1.5% of patients. These effects are localized and include burning, pruritus (itching), drying, scaling, cracking, pain, and irritant dermatitis.

Systemic and Serious Adverse Reactions

Although primarily used topically, the medication can be absorbed systemically, potentially leading to more serious adverse reactions affecting other systems, particularly with prolonged or extensive use. These documented effects include Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and the manifestations of Cushing's syndrome, which are major concerns related to systemic corticosteroid exposure. Effects on the Metabolism and Nutrition system, such as hyperglycemia and glucosuria, are also documented possibilities related to absorption.

Population-Specific Safety Considerations

  • Pediatric Patients: Regulatory documents note that children have a greater risk for systemic effects, including HPA axis suppression and intracranial hypertension, due to a higher skin surface area to body mass ratio. The safety and effectiveness of the ointment form have not been established in children under 10 years of age.
  • Exposure Risk: The potential for serious systemic effects is increased by factors that enhance absorption, such as prolonged use, application over large surface areas, or the use of occlusive dressings.

Safety Constraints

The product is formally constrained for use in individuals with a known hypersensitivity to any component of the formulation. Additionally, the ointment base contains paraffin and should not come into contact with latex-containing products, as this can damage the latex material.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with topical corticosteroids like Prednicarbate Ointment is defined by the potential for significant systemic absorption, which can lead to adverse effects. While this is not an acute toxicity risk, excessive or prolonged use can cause a systemic effect.

Documented Overdose Risk

Topically applied corticosteroids may be absorbed in sufficient amounts to produce systemic effects, with the primary documented risk being reversible suppression of the hypothalamic-pituitary-adrenal (HPA) axis. This suppression may lead to glucocorticosteroid insufficiency if treatment is abruptly withdrawn.

Risk factors that increase the potential for systemic absorption include applying the ointment to a large surface area, using it under occlusive dressings, or using it for prolonged periods.

Population Risk Factor Description
Pediatric Patients May be more susceptible to systemic toxicity due to a larger skin surface area relative to body mass.
Maternal Use Infants born to mothers who received substantial doses during pregnancy should be carefully monitored for hypoadrenalism.

Required Emergency Action

If HPA axis suppression is suspected or noted, the official guidance is to attempt to withdraw the drug, reduce the frequency of application, or substitute a less potent corticosteroid under medical supervision. Recovery of HPA-axis function generally occurs promptly after discontinuation.

When to Seek Immediate Medical Help

  • If overdose is suspected, contact a poison control center or seek medical care right away.
  • Call 911 or emergency services if the person experiencing the suspected overdose has serious symptoms, such as trouble breathing or passing out.

Therapeutic Uses of Prednicarbate Ointment

The medication is indicated for the symptomatic relief of inflammatory and pruritic manifestations.

Targeting Pronounced Itching and Visible Inflammation

Prednicarbate Ointment is commonly used to help with symptomatic relief from the key manifestations of corticosteroid-responsive skin disorders, such as Eczema (Dermatitis) and Psoriasis. It is applied to address symptom clusters that may become intense or disruptive, including pronounced or distressing itching (pruritus) and active inflammation (redness and swelling). By addressing symptoms related to inflammatory states, the medication contributes to general comfort during symptomatic periods and helps ease the overall symptom load.

Managing Chronic and Localized Skin Issues

The ointment form is relevant for conditions presenting with localized physical discomfort, such as dryness or thickening, often associated with chronic conditions, including Localized Neurodermatitis and areas of Anogenital Pruritus. This focused therapeutic approach offers symptomatic support that assists with maintaining functional stability and is relevant for easing discomfort in specific areas that have been affected over a long term.

Role in Mild-to-Moderate Symptom Management

The medication is commonly used when symptoms of inflammatory skin conditions reach a mild-to-moderate level of severity, requiring supportive symptom management. It is a relevant tool for managing both acute flare-ups and supporting symptom management during chronic phases. This is commonly used to provide supportive relief and may help patients cope more steadily with symptom fluctuations, assisting with maintaining functional stability when symptoms become more noticeable.

Quick Fact: Relief for Key Symptoms
Primary Target Pronounced itching and visible inflammation
Severity Role Management of mild-to-moderate symptoms
Condition Types Eczema, Psoriasis, and Localized Dermatoses
Benefit Supports stability and eases overall symptom load

Eligibility and Restrictions for Use

Who can and cannot use Prednicarbate Ointment?

The eligibility for using Prednicarbate Ointment is strictly defined by regulatory authorities based on age, physiological state, and pre-existing conditions.

Populations Allowed and Not Allowed

Category Regulatory Status Description
Adults Established Use Approved for use in patients 18 years and older.
Children Restricted Use Approved for patients 10 years of age and older. Use is not established and not recommended for children younger than 10.

Absolute Contraindications

Use of Prednicarbate Ointment is contraindicated and must not occur in patients with:

  • A known history of hypersensitivity or allergy to prednicarbate or any other ingredient in the formulation.
  • Specific local skin conditions, including Rosacea and Perioral dermatitis.
  • Untreated primary cutaneous infections, such as those caused by viruses (e.g., chickenpox), bacteria, fungi, or parasites.

Conditional Use Requirements

Use is highly restricted or requires caution in specific situations:

  • Pregnancy (Category C): Use is conditional and permitted only if the potential benefit justifies the potential risk to the fetus.
  • Lactation: Use requires caution; the ointment must not be applied to the breast or nipple area.
  • Sensitive Areas: Application to the face, groin, or axillae (armpits) should be limited due to the increased risk of local effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes the officially documented interaction patterns for Prednicarbate Ointment based strictly on government regulatory prescribing information. The interaction profile is primarily defined by the absence of systemic drug-drug interactions.

Official Interaction Structure

The regulatory documentation confirms there are no known significant systemic drug-drug interactions with co-administered oral medicines. This includes no documented pharmacokinetic interactions related to metabolic enzymes (such as CYP450) or drug transporters that would alter drug exposure.

Interaction Type Officially Documented Statement
Systemic Drug-Drug No known significant interactions.
Metabolic/Exposure No documentation of altered plasma levels or clearance.

Constraints with Non-Medicinal Products

Two non-systemic interactions are explicitly noted in the official regulatory data:

  1. Latex-Containing Products: The petrolatum-based vehicle used in the ointment formulation, which contains ingredients such as paraffin, is officially documented to interact physically with latex products (like condoms and diaphragms). This physical interaction can lead to material damage, potentially reducing the effectiveness of the latex product.
  2. Diagnostic Test Interference: The use of topical corticosteroids is associated with an interaction that may cause false-negative results when performing the Nitroblue-tetrazolium test for bacterial infection.

Mechanism of Action

Prednicarbate is a diesterified synthetic corticosteroid. Its mechanism of action begins with passive diffusion across the cell membrane, followed by binding to the intracellular glucocorticoid receptor (GR). This interaction triggers a conformational change in the GR, resulting in the dissociation of heat shock proteins. The activated Prednicarbate-GR complex then translocates to the nucleus where it functions primarily as a transcription regulator.

The complex binds to specific DNA sequences known as glucocorticoid response elements (GREs), leading to the transactivation of anti-inflammatory genes, such as those encoding lipocortin (Annexin A1). Lipocortin subsequently inhibits the enzyme phospholipase A2 (PLA2), thereby blocking the release of arachidonic acid from cell membrane phospholipids. This interruption precedes the synthesis of key inflammatory mediators, including prostaglandins and leukotrienes. Furthermore, the activated GR complex also promotes transrepression by inhibiting the activity of pro-inflammatory transcription factors, notably NF-kappaB and AP-1. This dual modulation reduces the cellular signaling involved in immune responses and capillary dilation, resulting in the physiological consequence of vasoconstriction at the local tissue level.

Dosage and Administration Information

How to Use Prednicarbate Ointment

Prednicarbate Ointment must be used exclusively as a topical dermatologic product, following the precise application and frequency instructions provided with the medication.

Administration and Dosage Schedule

Property Official Instruction
Route of Administration Topical (External use only)
Standard Dosing Apply a thin film to the affected area
Application Frequency Twice daily (e.g., morning and evening)
Application Method Rub in gently

The standard dosage regimen requires application of a thin film to the skin area twice per day. The ointment is a ready-to-use formulation and does not require dilution or preparation.

Contextual Use Instructions

To ensure proper use, specific procedural constraints are followed:

  • Avoid Occlusive Use: The treated skin area must not be bandaged, covered, or otherwise wrapped with an occlusive dressing (airtight material) unless specifically directed by a healthcare provider.
  • Avoid Contact: The ointment is strictly for external use; contact with the eyes, mouth, nose, or vagina must be avoided.
  • Treatment End Point: Therapy should be discontinued when control is achieved in the affected area.
  • Reassessment Requirement: If no improvement is observed within two weeks of starting treatment, the clinical diagnosis must be formally reassessed.

Use in Specific Populations

Instructions include age-specific rules for use:

Population Administration Rule
Children >= 10 Years Apply to the affected area twice daily (same as adult frequency)
Children < 10 Years Use and appropriate dosage must be determined by a healthcare provider

Recent Clinical Evidence

Research Evidence / Overview of Studies for Prednicarbate Ointment

Evidence for Use in Corticosteroid-Responsive Skin Conditions

Prednicarbate Ointment was studied for conditions like eczema (atopic dermatitis) and psoriasis, which are often associated with inflammatory or irritative states. Researchers have primarily used short-term, controlled clinical trials to explore patterns observed in patients during the study period. These studies have monitored outcomes related to physical discomfort, such as changes in redness (erythema), skin thickening, and scaling. The research highlights changes measured during the study period, and these findings describe patterns observed in the studies over defined time intervals, usually lasting a few weeks. Research provides context but not individual predictions.

How Prednicarbate Was Studied Compared to Other Treatments and Placebo

In many clinical trials, Prednicarbate Ointment was evaluated in settings that included a comparison group using an inactive substance (vehicle or placebo), or against other commonly used topical corticosteroid medications. Research examined how changes in outcomes related to physical discomfort were tracked. When compared to the inactive vehicle, patterns of symptom measurement variation were observed between treatment groups over short time intervals. Comparative evidence is lacking for many of the newer treatments available today, and certainty remains low when comparing it to a wide range of current standard-of-care options.

Long-Term Studies and Follow-Up Data

Prednicarbate Ointment was studied for short-term and acute management, typically for one to three weeks. Trials monitored measurements of plasma cortisol levels in some trials to monitor physiological strain or stress, especially when applied over large body areas. The long-term effects are not fully established because follow-up durations were limited. There is limited information for long-term outcomes regarding potential long-term dermal changes, which are not well documented by controlled trials, or the evolution of symptom patterns over many months or years.

Evidence in Specific Patient Groups

Researchers also explored the use of Prednicarbate Ointment in specific populations, such as pediatric patients (children) over the age of 10. However, data for certain groups remain insufficient. Specifically, the data related to children younger than 10 years of age are not fully established by the existing studies. Similarly, limited information is available for how the ointment was observed in trials involving older adults or those with complex medical conditions. Therefore, results apply only to the populations studied in the short-term trials that are currently available.

Key Studies & References

  1. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids (Comparative RCT)
  2. 1 PRODUCT MONOGRAPH PrDERMATOP® OINTMENT (prednicarbate ointment, 0.1%) (Canadian Regulatory Document, includes pediatric exclusion for ointment)

Frequently Asked Questions (FAQ)

Common questions about Prednicarbate Ointment (FAQ)

Q: What is Prednicarbate Ointment used to treat?

A: According to the official product information, Prednicarbate Ointment is used to treat mild to moderate skin conditions that respond to corticosteroids. These conditions include various forms of eczema (atopic, neurodermatitis, contact eczema), and psoriasis. It is used to relieve the associated symptoms like inflammation, redness, and itching.

Q: What is the active ingredient in Prednicarbate Ointment?

A: The active ingredient is prednicarbate. Regulatory documents classify prednicarbate as a corticosteroid, specifically a non-halogenated corticosteroid. This means it is a type of medicine intended to help reduce inflammation in the body.

Q: How does prednicarbate work to treat skin conditions?

A: Prednicarbate is a glucocorticoid, which is a type of steroid that acts on the skin cells. According to official product information, it works by suppressing the body's inflammatory response. This action is intended to help manage the symptoms of redness, swelling, and itching associated with certain skin conditions.

Q: Can Prednicarbate Ointment be used on the face?

A: Official information indicates that use on the face typically requires specific instruction from a healthcare provider. The skin on the face is thinner and may absorb the medicine more easily. Regulatory sources recommend that if it is used on the face, the treatment is generally for a limited duration.

Q: Is there a maximum duration for using Prednicarbate Ointment?

A: Yes, regulatory documents note that continuous application of Prednicarbate Ointment is generally limited to no more than three weeks for adults. For children, the treatment period is usually shorter. Official guidance notes that long-term use or application over large body areas may increase the risk of side effects.

Q: Can children use Prednicarbate Ointment?

A: Yes, Prednicarbate Ointment can be used in children, but official guidance stresses caution and use for the shortest possible duration. Regulatory sources suggest that treatment for children is typically limited to no more than one week. Official information indicates that using the medicine under an occlusive dressing (such as a diaper) is generally avoided for children.

Q: What should I do if I forget a dose of Prednicarbate Ointment?

A: Regulatory documents describe the typical guidance for a missed application: continuing the prescribed treatment schedule when the next application is due. Official information notes that a user should avoid applying extra ointment to compensate for the missed application, as adherence to the prescribed schedule is considered important.

How should Prednicarbate Ointment be stored and disposed of?

How to Store and Dispose of Prednicarbate Ointment

Prednicarbate Ointment must be stored under specific environmental conditions as defined by regulatory labeling. The product requires storage at controlled room temperature, which corresponds to a range of 59 F to 86 F (15 C to 30 C).

Storage Requirements

Storage Condition Requirement
Temperature Range 59 F to 86 F (15 C to 30 C)
Environmental Protection Keep from freezing, heat, moisture, and direct light
Container Must be stored in a closed container
Child Safety Must be stored out of the reach of children

Disposal Instructions

Do not use the medicine past its expiration date. Unused or expired Prednicarbate Ointment should not be flushed down a toilet or poured into a drain. Patients must consult a healthcare professional or pharmacist for instructions on proper disposal, such as using a drug take-back program. If a take-back program is unavailable, non-flushable medicines may be mixed with an undesirable substance, sealed, and placed into household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Prednicarbate Ointment found in:

A-Z Index: